DMT (N,N-dimethyltryptamine) is a powerful psychedelic that produces intense visual hallucinations, altered perception of time and space, and often a feeling of entering an entirely different reality. When inhaled or injected, the effects hit within seconds, peak around 2 minutes in, and fade within 15 to 30 minutes. When consumed orally as part of ayahuasca, the experience stretches to 4 to 6 hours. Here’s what happens in your brain and body during that window.
How DMT Works in the Brain
DMT is structurally similar to serotonin, the neurotransmitter that regulates mood, perception, and sleep. It binds to multiple serotonin receptors, with the 5-HT2A receptor considered the primary driver of its psychedelic effects. But DMT isn’t a one-trick molecule. It also interacts with dopamine receptors, acetylcholine receptors, glutamate receptors, and a less-understood target called the sigma-1 receptor. This broad activity across multiple brain systems helps explain why the experience feels so all-encompassing, affecting vision, emotion, body sensation, and sense of self simultaneously.
When DMT activates serotonin receptors in the prefrontal cortex, it increases the firing rate of pyramidal neurons, the brain cells responsible for complex thought and perception. This flood of neural activity appears to disrupt normal information filtering, allowing the brain to generate vivid internal imagery and novel patterns of connectivity between regions that don’t usually communicate so directly. In lab studies, DMT slows reaction time, decreases alertness on cognitive tasks, and shifts brain activity in ways that look profoundly different from normal waking consciousness.
Interestingly, DMT is produced naturally in the mammalian brain. A team at the University of Michigan identified the enzymes required to synthesize DMT not only in the pineal gland but also in the neocortex and hippocampus, regions critical for learning and memory. The levels detected were comparable to other brain signaling chemicals like serotonin and dopamine. No one yet knows what role endogenous DMT plays, though the researchers also found that levels increased in rats experiencing cardiac arrest.
What the Experience Feels Like
When inhaled, DMT produces effects almost immediately. Within the first 30 seconds, geometric patterns and intensely vivid colors typically fill your visual field, even with eyes closed. Many people describe a sensation of being “launched” or pulled rapidly through a tunnel of light and pattern. At lower doses, this visual distortion and altered headspace is the extent of the experience.
At higher doses, people describe what’s commonly called a “breakthrough,” where the sense of being in your physical body and surroundings dissolves completely. You may feel transported to an entirely different space, often described as hyper-real rather than dreamlike. A striking feature unique to DMT compared to other psychedelics is how frequently people report encountering what feel like autonomous beings or entities. These encounters feel interactive and emotionally charged, and many people report receiving information or communication during them, though the content is often difficult to articulate afterward.
The emotional range during a DMT experience is extreme. Feelings of awe, love, terror, confusion, and euphoria can cycle rapidly or layer on top of each other. Time distortion is nearly universal. What lasts 10 to 15 minutes by the clock can feel like hours or even longer. As the effects fade, most people return to baseline within 30 minutes with a clear head, though a sense of wonder or disorientation can linger.
Physical Effects on the Body
DMT raises your heart rate quickly. In clinical studies using intravenous DMT, heart rate increased significantly within the first minute, peaking about 2 minutes after administration with an average jump of roughly 35 beats per minute above baseline. This elevation lasted about 24 minutes before returning to normal. Researchers noted that the initial spike was partly anxiety-related, as the heart rate began dropping back even while the drug was still active. Blood pressure also rises, though precise measurements from clinical settings are less well documented.
Other common physical effects include dilated pupils, rapid eye movements, increased body temperature, and sometimes nausea, particularly with ayahuasca (where vomiting is so common it’s considered part of the process). Some people experience chest tightness, trembling, or a buzzing sensation throughout the body during onset. These physical effects generally resolve completely as the psychological experience fades.
Inhaled vs. Oral (Ayahuasca)
DMT on its own is nearly inactive when swallowed. Your gut contains an enzyme called monoamine oxidase A (MAO-A) that breaks it down before it ever reaches your bloodstream. Ayahuasca solves this by combining DMT-containing plants with plants rich in beta-carboline alkaloids, particularly harmine and harmaline, which block that enzyme. With MAO-A inhibited, DMT survives digestion and reaches the brain.
This changes the experience dramatically. Instead of a 15-minute rocket ride, ayahuasca produces effects lasting 4 to 6 hours. The onset is slower (typically 30 to 45 minutes), the peak is less abrupt, and the overall experience tends to unfold in waves. The MAO inhibition also shifts how DMT is metabolized throughout the body, increasing the production of several secondary metabolites that may contribute their own effects to the experience. The beta-carbolines themselves have mild psychoactive properties, adding to the complexity of the ayahuasca experience compared to pure DMT.
Psychological Risks
DMT does not appear to cause physical dependence or organ damage with occasional use. The primary risks are psychological. The experience can be overwhelmingly intense, and difficult or terrifying experiences are common, particularly at higher doses or in uncontrolled settings. For most people, even a frightening experience resolves without lasting harm once the drug wears off.
The more serious risks apply to specific populations. People with a personal or family history of schizophrenia, schizoaffective disorder, or bipolar I disorder face an elevated risk of prolonged psychosis triggered by DMT or any classic psychedelic. The same applies to people who experience psychotic symptoms alongside depression. For those with significant unresolved trauma, DMT can surface repressed memories or re-create traumatic experiences with full sensory intensity, which can be destabilizing without adequate psychological support.
Because DMT activates serotonin receptors, combining it with medications that raise serotonin levels creates a risk of serotonin syndrome, a potentially life-threatening condition involving dangerously high body temperature, muscle rigidity, and seizures. This is especially relevant for anyone taking SSRI antidepressants or MAO inhibitors. The risk is compounded with ayahuasca, which already contains MAO-inhibiting compounds.
People with cardiovascular conditions, uncontrolled high blood pressure, a history of heart attack or stroke, epilepsy, or who are pregnant are also at elevated physical risk due to the blood pressure and heart rate spikes DMT produces.
Clinical Research
DMT is being studied as a potential tool for treating depression and anxiety, following the broader wave of psychedelic research that has gained momentum over the past decade. Its short duration makes it particularly interesting for therapeutic settings, since a guided session could fit within a standard clinical appointment rather than requiring the 6 to 8 hours that psilocybin sessions demand. Early-phase clinical trials have been completed examining related compounds for anxiety and depression in patients with cognitive impairment, though published results from these trials are still limited. Extended-infusion protocols, where DMT is administered intravenously over a longer period to sustain the experience, are also being explored as a way to combine the molecule’s potency with a more controllable timeline.